Navellier & Associates’s CVS Health CVS Stock Holding History

Navellier & Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,675	Closed	-$231K	–	336
2024 Q3	$231K	Hold	3,675	–	–	0.03%	299
2024 Q2	$217K	Hold	3,675	–	–	0.03%	318
2024 Q1	$293K	Hold	3,675	–	–	0.04%	289
2023 Q4	$290K	Hold	3,675	–	–	0.04%	276
2023 Q3	$257K	Buy	+3,675	New	+$260K	0.04%	280
2016 Q1	–	Sell	-271,684	Closed	-$26.6M	–	267
2015 Q4	$26.6M	Sell	271,684 -30,251	-10%	-$2.96M	2.92%	5
2015 Q3	$29.1M	Sell	301,935 -46,791	-13%	-$4.92M	2.93%	5
2015 Q2	$36.6M	Buy	348,726 +1,388	+0.4%	+$142K	3.21%	4
2015 Q1	$35.8M	Sell	347,338 -416,368	-55%	-$42.1M	3.25%	4
2014 Q4	$73.6M	Sell	763,706 -9,280	-1%	-$818K	3.67%	5
2014 Q3	$61.5M	Buy	+772,986	New	+$60.9M	3.09%	8

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Navellier & Associates's CVS Position: Q4 2024 in Review

Navellier & Associates sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,675 shares — an estimated $231K sold.

Navellier & Associates first reported a position in CVS in Q3 2014 and held it in 11 quarters. The position peaked at $73.6M in Q4 2014. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

Navellier & Associates reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
Navellier & Associates sold 3,675 CVS Health shares in Q4 2024, an estimated $231K.
Navellier & Associates first reported a position in CVS Health in Q3 2014 and held it in 11 quarters.
Navellier & Associates's CVS Health position peaked at $73.6M in Q4 2014.
1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Navellier & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.